[maxerickson]

Last week, Lothar Wieler, head of Germany’s Robert Koch Institute for Infectious Diseases, said there was no evidence that patients who received the vaccine were more likely than patients of a similar age group to suffer blood conditions.

Is that guy wrong or basing the statement on outdated information?

[Sol-]

Might be outdated, since he talks about clotting generally but the agency in charge of halting the vaccinations mentions a specific rare complication today [1]:

> accumulation of a special form of very rare cerebral vein thrombosis (sinus vein thrombosis) in connection with a deficiency of blood platelets (thrombocytopenia) and bleeding in temporal proximity to vaccinations with the COVID-19 vaccine AstraZeneca.

Perhaps really just a bad batch somehow if this particular complication wasn't observed in the UK.

[1] https://www.pei.de/EN/newsroom/hp-news/2021/210315-pei-infor...

[fabian2k]

There is new data, and the statement from the Paul Ehrlich Institute refers specifically to a specific type of thrombosis. The PEI is the institute responsible for vaccines, the RKI is for infectious diseases in general.

It's hard to say if this is a good decision, my impression is that this is too risk-averse given the real danger and very significant chance of COVID 19 infections. But it does seem to be based on different data than just a few days ago.

PEI Statement:

https://www.pei.de/EN/newsroom/hp-news/2021/210315-pei-infor...